Renal Nerve Stimulation in Uncontrolled Hypertensive Patients Undergoing Renal Denervation
Recruiting now · Phase 4
Conditions studied: Hypertension
In brief
Study design: Investigator initiated, single center The study is aimed 1\) To investigate the blood pressure (BP) change to renal nerve stimulation(RNS), and subsequently perform a renal denervation(RDN) procedure 1\) to verify the cutoff value (RNS-induced systolic BP change \<20 mmHg in post-RDN patients) could be a useful clinical endpoint in RDN therapy, and test the hypothesis that intense RDN could improve the efficacy of RDN.
Key facts
- Study ID
- NCT05421767
- Run by
- National Taiwan University Hospital
- People needed
- 60
- Starts
- 2022-06-24
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2022-06-16
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with hypertension (HTN), including
- 24-hour ambulatory blood pressure >130/ 80 mmHg
- Age 20-80 years
- Glomerular filtration rate >45 mL/min
You may not qualify if…
- Unsuitable renal artery anatomy computed tomographic angiography (main renal artery lumen diameter ≤3 mm or a total length <20 mm of the main arteries).
- untreated secondary HTN, including hyperaldosteronism, pheochromocytoma, renal artery stenosis(>50% stenosis)
Where it is running
- National Taiwan University Hospital — Taipei, Taiwan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.